Vaccination in SLE patients

Abstract

Get full access to this article

View all access options for this article.

References

Zandman-Goddard

Shoenfeld

. Infections and SLE. Autoimmunity 2005; 38: 473–485.

Falagas

Manta

Betsi

Pappas

. Infection-related morbidity and mortality in patients with connective tissue diseases: A systematic review. Clin Rheumatol 2007; 26: 663–670.

World Health Organization. Vaccine safety basics e-learning course, http://vaccine-safety-training.org (accessed October 2018).

Ljungman

. Vaccination of immunocompromised patients. Clin Microbiol Infect 2012; 18(Suppl 5): 93–99.

Papadopoulou

Sipsas

. Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases. Rheumatol Int 2014; 34: 151–163.

Gov.UK. Department of Public Health England. Immunisation against infectious disease: The green book, https://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book (accessed October 2018).

Rahier

Moutschen

Van Gompel

et al.

Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) 2010; 49: 1815–1827.

van Assen

Agmon-Levin

Elkayam

et al.

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011; 70: 414–422.

Gordon

Amissah-Arthur

Gayed

et al.

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus. Rheumatology (Oxford) 2018; 57: e1–e45.

10.

Bernatsky

Hudson

Suissa

. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology (Oxford) 2007; 46: 1157–1160.

11.

Cervera

Khamashta

Font

et al.

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 82: 299–308.

12.

Hak

Nordin

Wei

et al.

Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed care organizations. Clin Infect Dis 2002; 35: 370–377.

13.

Nath

Mant

Luxton

et al.

High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum 2007; 57: 619–625.

14.

Tam

Chan

et al.

Natural history of cervical human papillomavirus infection among women with systemic lupus erythematosus. Ann Rheum Dis 2009; 68(Suppl 3): 128–128.